avarol has been researched along with dinoprostone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bégin, ME; Gasić, M; Klöcking, R; Matthes, E; Müller, WE; Sarma, AS; Schröder, HC | 1 |
| Amigó, M; De Rosa, S; Iodice, C; Mitova, M; Payá, M; Terencio, MC | 1 |
2 other study(ies) available for avarol and dinoprostone
| Article | Year |
|---|---|
Avarol restores the altered prostaglandin and leukotriene metabolism in monocytes infected with human immunodeficiency virus type 1.
Topics: Antiviral Agents; Arachidonate 5-Lipoxygenase; Cyclooxygenase Inhibitors; Dinoprostone; HIV-1; Leukotriene B4; Lipoxygenase Inhibitors; Monocytes; Prostaglandin-Endoperoxide Synthases; Sesquiterpenes | 1991 |
Potential antipsoriatic avarol derivatives as antioxidants and inhibitors of PGE(2) generation and proliferation in the HaCaT cell line.
Topics: Antioxidants; Dinoprostone; Free Radical Scavengers; Humans; Inhibitory Concentration 50; Italy; Keratinocytes; L-Lactate Dehydrogenase; Salicylates; Sesquiterpenes; Structure-Activity Relationship | 2004 |